Announcements

14 August 2024
Proteomes | Promotional Video

6 May 2026
MDPI INSIGHTS: The CEO's Letter #34 - MDPI US Office, Coatings 2026, Media and Partnerships, Recapping Poland Summit & Serbia Salon

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Opens First US Office in Philadelphia

I am delighted to highlight an important milestone in MDPI’s continued global development: the recent opening of our first office in the United States, located in Philadelphia.

This marks a significant step in building our engagement with one of the world’s most important research communities. The new office will serve as a hub for supporting scholars across the US, creating closer connections and more localized support.

As highlighted in recent coverage by our press release in InPublishing, this expansion reflects MDPI’s broader commitment to growing our international presence while remaining focused on the needs of the research community.

A Key Market for Research and Collaboration

The United States continues to play a central role in global research. To date, MDPI has published more than 237,000 articles affiliated with US institutions, and we collaborate with nearly 12,000 Editorial Board Members across the country. These relationships are fundamental to our mission of supporting Open Access and advancing scientific communication.

The opening of this office is not just about geography; it is about proximity to the communities we serve. It allows us to better understand the evolving needs of researchers while continuing to build collaboration and trust within the academic ecosystem.

The Team Behind this Milestone

This milestone reflects the efforts of teams across MDPI. I extend a special thank-you to Bob Vrooman (Head of Business Development, MDPI), who is leading this expansion, as well as to our colleagues in Toronto and across our North American teams for their continued support.

Bob shared: “MDPI is already a trusted partner of the North American research community, due in no small part to our dedicated team in Canada. Launching our first US office in Philadelphia is a great first step towards expanding MDPI’s market share and recognition in the US. I’m thrilled to be a part of this new phase in MDPI’s journey.”

As we continue to grow, our focus remains on supporting researchers globally and advancing Open Access with integrity.

Impactful Research

Coatings 2026: Highlights from Our Latest MDPI Conference (20-22 April)

I am pleased to share the successful completion of MDPI conference Coatings 2026, which took place last week in Athens from 20 to 22 April 2026. This conference brought together a diverse international community of researchers, industry experts, and partners, highlighting MDPI’s role not only as a publisher but also as a platform for scientific exchange and collaboration.

Conference Highlights

Coatings 2026 in numbers:

  • The event attracted approximately 140 participants from 25 countries
  • 143 submissions and a strong scientific program of talks and posters
  • 2 keynote speakers and a wide range of invited contributions
  • 7 sponsors and 11 media partners supporting the event

Scientific Programme

The program centered on “Safe and Sustainable by Design,” reflecting the growing importance of sustainability, regulatory frameworks, and technological innovation in materials science. Topics ranged from advanced coating technologies and additive manufacturing to AI-driven simulations and strategies to phase out potentially harmful substances in industrial processes.

Importantly, the conference brought together both academic and industrial perspectives, creating a space for dialogue on how research can translate into real-world impact. This is important as industries navigate environmental challenges, evolving regulations, and the need for more sustainable and circular approaches to production.

Thank You!

I would like to thank the entire conference team for their work in organizing this successful event. As we continue to grow, conferences like this play an important role in building our connection with global research communities, supporting interdisciplinary collaboration, and positioning MDPI at the intersection of science, technology, and societal impact.

Members from Exelisis and MDPI EU Conference & Social Media team at the Coatings 2026 Conference in Athens, Greece.

Inside MDPI

Recent Media Coverage and Partnerships

Over the past two months, news from MDPI has enjoyed strong visibility across international publishing and academic media, reflecting our continued expansion and the increasing relevance of our work within the research community.

Below are some highlights covering partnerships, institutional agreements, and milestones that continue to shape our position in publishing – some of which are featured in leading industry platforms such as InPublishing, which is highly selective and reflects the growing recognition of MDPI’s growth within the publishing ecosystem.

Key Press Releases & Coverage (March–April 2026)

  • MDPI × Sikt (Norway): Partnership Renewal

    We renewed our national Open Access agreement with Sikt, a key consortium partnership, continuing to support researchers across Norway through this partnership. The renewal was covered by several international publishing trade outlets.

    Covered by: Research Information, STM Publishing News, ALPSP, Europe Says

  • MDPI × Jisc (UK): New Two-Year Open Access Agreement

    A new two-year agreement with Jisc significantly expands MDPI’s footprint across UK academic institutions. Coverage appeared across major publishing industry titles in the UK and internationally.

    Covered by: InPublishing, Research Information, STM Publishing News, ALPSP

  • MDPI Opens First US Office

    The opening of our first US office marks an important milestone in our North American expansion to build engagement with one of the world’s leading research communities.

    Coverage by: EurekAlert!, InPublishing, EdTech Innovation Hub, STM Publishing News, ALPSP

  • MDPI × SIGG: Italian Society of Gerontology and Geriatrics

    We established a new partnership with the Italian Society of Gerontology and Geriatrics (SIGG), adding to our growing portfolio of society collaborations.

    Coverage by: EurekAlert!, STM Publishing News, ALPSP

  • MDPI × Fast Track Health: New Journal Launch

    The launch of a new journal in partnership with Fast Track Health reflects our continued expansion into emerging areas of health innovation.

    Coverage by: EurekAlert!, Scienmag, STM Publishing News, ALPSP

  • MDPI 2025 Annual Report

    Our 2025 Annual Report was also widely covered across international media, highlighting a 12% increase in submissions and continued investment in research integrity, infrastructure, and partnerships.

    Coverage by: EurekAlert!, Research Information, STM Publishing News, ALPSP, Choice 360

Coverage also spanned multiple regions including Poland, Romania and South Korea, reflecting our ongoing efforts to communicate more effectively with regional research communities.

Looking Ahead

This coverage shows that MDPI is growing and building on its position through partnerships, visibility, and engagement across regions. As we continue to expand, our focus remains on supporting researchers globally, building on our institutional collaborations, and advancing Open Access with integrity.

Thank you to all teams involved in delivering these initiatives, and to our External Affairs team for ensuring our work is effectively communicated across the global publishing landscape!

Coming Together for Science

Recapping MDPI Poland Summit 2026 in Krakow (23 April)

On 23 April 2206, we hosted the first MDPI Poland Summit 2026 in Kraków, bringing together an engaged group of editors, researchers, and academic leaders from the country.

The Poland Summit welcomed some 45 participants, including Editors-in-Chief, Associate Editors, and Editorial Board Members, many with strong academic track records and international recognition.

Our engagements were open and constructive, focusing on MDPI’s positioning and reputation in Poland, alongside community interest in supporting our development, with active participation across our sessions, including Q&A and panel discussions.

MDPI Poland Summit Programme

From research integrity and peer review quality to AI in publishing and the future of academic communication, the agenda featured important topics currently shaping our industry.

During the day, MDPI colleagues shared a series of presentations covering:

  • MDPI’s performance, growth, and impact in Poland: Stefan Tochev (CEO)
  • Engagement with Academic Community: Dr. Marta Colomer (Public Affairs Lead)
  • Research Integrity and Publication Ethics: Anna Pena (Research Integrity Manager)
  • MDPI Editorial Process and Peer-Review Quality Metrics: Dr. Liliane Auwerter (Conference Organizer)
  • AI in the Publishing Industry – Challenges, Innovation and MDPI’s vision: Dr. Enric Sayas (AI Product Owner)
  • Panel Session: The Future of Academic Publishing, moderated by Dr. Marta Colomer 

Poland as a Key Market for Open Access

The summit also highlighted the importance of Poland within the global research landscape.

In 2025:

  • 75% of publications in Poland were made in Open Access
  • 71% of those in Gold Open Access
  • and over 344,000 publications produced in the last five years

MDPI plays a significant role in the Polish publishing ecosystem:

  • #1 Open Access publisher in Poland
  • 17% share of Open Access publications in 2025
  • More than 12,500 publications from Polish institutions in 2025
  • More than 91,000 publications overall since 1996

Looking Ahead

Events like the Poland Summit are an important part of how we evolve as an organization. They allow us to share the latest developments of MDPI and listen directly to our researchers and editors to better understand the market and align our development with the needs of the local community.

As MDPI continues to grow, this type of engagement will remain essential in ensuring that we are not only scaling globally, but doing so in a way that is aligned, trusted, and collaborative.


With Igor Matic (Office Manager, Krakow, Poland, MDPI) at the MDPI Poland Summit in Krakow.

Closing Thoughts

Recapping MDPI Serbia Salon 2026 in Belgrade (22 April)

On 22 April 2026, we hosted the MDPI Serbia Salon 2026 in Belgrade. The Salon welcomed over 50 participants, including more than 40 invited scholars from leading Serbian institutions, alongside colleagues from MDPI. The event also marked two important milestones: 30 years of MDPI and 10 years of our presence in Serbia, making it a celebration and an opportunity for reflection.

A Platform for Exchange

The Salon was designed not just as a series of presentations, but as a place for dialogue. Throughout the day, discussions focused on important topics around publishing today: research integrity and editorial standards, journal indexing and visibility, the evolving role of artificial intelligence, and funding and support for Open Access publishing.

Program Overview

  • Opening the Salon MDPI Serbia 2026 – Serbia results and direction: Emir Ramadani (Operations Manager)
  • Update on MDPI’s performance and growth: Stefan Tochev (CEO)
  • Collaboration with MDPI – A personal perspective: Prof. Dr Srećko Stopić (Editorial Board Member)
  • Linking Scientific Quality and Visibility: The role of indexing in publishing
  • Research integrity and editorial ethics: Ana Stanković (Research Integrity Specialist)
  • Artificial Intelligence in Scientific Publishing – Challenges, innovations and vision of MDPI: Dr Miloš Čučulović (Head of Technology Innovation)

It was encouraging to see the high level of engagement and discussion with the local academic community.

Publishing in Serbia

With 10 years of MDPI in Serbia (since 2016) and over 620 colleagues across 10 departments spread across offices in Belgrade and Novi Sad, MDPI continues to invest in the long-term development of the research community in Serbia and beyond.

Some high-level indicators illustrate both the strength of the local research ecosystem and MDPI’s role within it:

  • 12,910 total publications in Serbia in 2025, of which 8,708 (67%) were Open Access (of which, in turn, 75% were Gold OA)
  • A total of more than 55,000 publications (2021–2025), with 68% published Open Access
  • 2,122 MDPI publications from Serbian institutions in 2025
  • 25% of all Open Access publications in Serbia are published with MDPI
  • More than 11,000 MDPI publications from Serbian institutions since 1996
  • More than 75 Editorial Board Members from Serbia, including Editors-in-Chief and Associate Editors.

These figures reflect the growth of OA publishing in Serbia and the strong collaboration between MDPI and Serbia's research community.

Top 5 Publishers in Serbia (MDPI #1 with steady growth)

Looking Ahead

Research integrity and artificial intelligence will remain central topics for the industry. At the same time, clear communication of editorial processes will be essential in building trust and transparency.

Workshops and direct engagement remain among the most effective ways to strengthen these connections. As Open Access funding models continue to evolve, new opportunities for collaboration are emerging across institutions, publishers, and the broader research community.

Thank You!

The excellent feedback from participants shows the value of creating spaces where ideas can be exchanged openly and constructively. Sincere thanks to everyone who contributed to the success of this event: our speakers, participants, and especially the MDPI Serbia team for their great organization and support.

Stefan Tochev
Chief Executive Officer
MDPI AG

27 April 2026
Meet Us at the 60th Annual Scientific Meeting of the European Society for Clinical Investigation 2026 (ESCI), 3–5 June 2026, Lisbon, Portugal


Conference:
60th Annual Scientific Meeting of the European Society for Clinical Investigation (ESCI)
Date: 3–5 June 2026
Location: Lisbon, Portugal

MDPI will participate as an exhibitor at the 60th Annual Scientific Meeting of the European Society for Clinical Investigation. We welcome researchers and professionals to visit our booth and engage with our team.

The 60th Annual Scientific Meeting (ASM) of the European Society for Clinical Investigation (ESCI) will be held from 3 to 5 June 2026. It can bring together 500–600 scientists, medical professionals, and innovation leaders from across Europe and beyond to explore the theme “Research in Action: Building Healthier Futures”. The scientific program will feature a rich blend of disciplines—spanning cardiovascular science, endocrinology, obesity, metabolism and MASLD, mitochondrial biology, oncology and immunology, rheumatology, and neurosciences. This year, we will shine a spotlight on life transitions in women, unravelling health and disease journeys from pregnancy to menopause. The program will also highlight today’s most transformative biomedical breakthroughs, from AI-enabled diagnostics to gene editing and precision therapies.

The following open access journals will be represented:

  • Reports;
  • Medicina;
  • Diagnostics;
  • JPM;
  • BioMed;
  • Complications;
  • Pharmacy;
  • NeuroSci;
  • JCRM;
  • Current Oncology;
  • JCM;
  • Physiologia;
  • Proteomes;
  • Diseases.

If you are planning to attend the above event, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information, please visit https://barcelo.eventsair.com/QuickEventWebsitePortal/esci-2026/web.

24 April 2026
Prof. Dr. William Gerwick Appointed Chair of the 2026 Tu Youyou Award Committee

We are honored to announce that Prof. Dr. William Gerwick will serve as the Chair of the 2026 Tu Youyou Award Committee.

A world-renowned authority in marine natural products chemistry and pharmacology, Professor Gerwick is a Distinguished Professor at both the Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego (UCSD). His pioneering work at the intersection of ocean sciences and drug discovery makes him a fitting leader for an award centered on transformative medicinal breakthroughs.

Under Professor Gerwick’s stewardship, the 2026 Tu Youyou Award Committee will focus on recognizing innovative and impactful research in natural products chemistry and medicinal chemistry, particularly work with the potential to drive meaningful advances in both scientific understanding and human health.

To provide further insight into his perspectives, we include below an interview with Professor Gerwick, in which he reflects on his scientific journey, his views on the field, and his vision for the Tu Youyou Award.

A Conversation with the Chair


1. Could you please introduce yourself and your research journey?

My research focuses on the natural products of marine algae and cyanobacteria, their application in medicine, their biosynthesis using genomic approaches, and innovative methods in the structure elucidation of natural products.

I received my BS degree from the University of California at Davis, my PhD from the University of California at San Diego, and conducted postdoctoral work at the University of Connecticut. After a couple of years in a junior faculty position at the Department of Chemistry at the University of Puerto Rico, I spent 21 years as Professor of Pharmacy at Oregon State University. In 2005, I returned to my PhD institution at the Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego, where I am currently a Distinguished Professor of Oceanography and Pharmaceutical Sciences.

Throughout my career, I have been dedicated to advancing the field through both leadership and mentorship. I have served as president of the American Society of Pharmacognosy, chaired and co-chaired several major research conferences, and served as an associate editor for the Journal of Natural Products. I am a Fellow of the American Association for the Advancement of Science (AAAS) and of the American Society of Pharmacognosy. I have trained over 100 doctoral and postdoctoral students, and my research group has published nearly 500 papers and more than 25 patents on topics in the natural product sciences and medicinal chemistry.

2. What motivated you to accept the role of Chair of the 2026 Tu Youyou Award Committee?

Of course, I am a huge supporter of all awards that are given in recognition of excellent scientific research, and especially so in the natural products sciences and medicinal chemistry. However, this award is truly special in that it recognizes scientific excellence as well as impact, and is given in the name of an individual, Tu Youyou, who clearly had many challenges along the path to reach the pinnacle of her success. Not only was she the first Chinese person to win a Nobel prize in this area, but she was also the first Chinese woman to receive a Nobel prize, and this was achieved without graduate education in China or elsewhere. It’s a true testament to what can be achieved by hard work, determination, and vision. To read the history of her extraordinary approach to discovering novel antimalarial compounds from Traditional Chinese Medicine is truly inspirational. It is, therefore, the inspiration provided by the extraordinary life and career of Tu Youyou that motivated me to accept the Chair of the Award Committee for 2026.

3. How do you view the role of natural products chemistry and medicinal chemistry in today’s scientific landscape, and what major advances over the past decade have shaped this field?

A quite remarkable integration of fields is currently transforming natural products science and medicinal chemistry. In natural products, we are seeing integration of different omics methods, from metabolites to proteins to nucleic acids. Sophisticated biological and pharmacological approaches are driving the discovery of exquisitely potent and selective natural products. Advances are being made to integrate molecular-level recognition of natural products with chemical ecological studies, and sophisticated methods of structure determination using Artificial Intelligence or pioneering new tools such as microED are being applied with increasing frequency. High-level synthetic methodologies, such as protecting group-free synthetic routes, are enhancing medicinal chemistry, accelerating the identification of lead molecules with attractive pharmaceutical properties at an increasing pace.

4. How do you consider the balance between fundamental discovery (e.g., new molecules or mechanisms) and practical impact (e.g., therapeutic applications)?

Many individuals are excellent scientists and mentors, and have essential roles in developing our culture that values science and the scientific method. It should also be pointed out that not all scientific discoveries are going to have a broad societal impact, but they are nevertheless critical to the overall body and structure of science. But it is a truly remarkable individual who makes a key scientific discovery, recognizes its potential value to society in general, and then has the skills and determination to bring it forward as a useful product. That was the type of person the Tu Youyou is, and that is the type of person who is honored by the prize in her name.

5. What do you see as the key challenges or opportunities currently facing the field?

We are on the crux of an amazing revolution in many of the sciences, including natural products and medicinal chemistry; the purposeful application of Artificial Intelligence to solving many of the difficulties involved in the search for new pharmaceuticals from Nature. AI is transforming how we select organisms for study, what pharmaceutical targets to go after, rapidly resolving the chemical structures of new compounds, identifying efficient routes to their chemical synthesis, understanding their molecular mechanisms of action, and finally, designing their clinical application. The role of people in these pursuits is changing. Increasingly, the human role will be providing overall vision: what can we do? What should we do? And it is important to remember that AI is providing hypotheses, not truth. Scientists with expert domain knowledge will be critical for discerning the correctness of hypotheses put forth by AI. Altogether, advances in technology, expanding knowledge, and the appropriate use of AI methods are preparing society to be able to address emerging diseases, such as pandemics, as well as conditions that are not effectively treated by currently existing therapeutics.

6. How do you expect the Tu Youyou Award to contribute to the advancement of natural product chemistry, medicinal chemistry, and human health over the coming years?

The Tu Youyou Award is potentially transformative for the broad fields of natural products science and medicinal chemistry as it brings a significantly increased level of visibility to these topics and their contributions to human health. It will be crucial to have excellent communication to news agencies, social media and other communication outlets so that the general public is informed and educated on the high impact of these natural product/medicinal chemistry contributions. This will bring increased funding, attract promising students, and generally enrich the interface of these fields with the health sector.

7. What message would you like to convey to the research community and the public during this open nomination phase?

This prize gives broad societal visibility to the role that natural products have had in shaping a majority of our current medicines, as well as understanding the life forms with whom we share the planet. Further, it recognizes a woman scientist working under sub-optimal conditions who could persevere and make discoveries of global impact. The prize and what it represents, therefore, inspires current and future generations to engage in the study of Nature and its relationship to Human Health, to overcome adversity, and to aspire to making one’s life impactful.

About the Tu Youyou Award

Established in 2016, the Tu Youyou Award seeks to honor those who excel in the fields of natural products chemistry and medicinal chemistry. This award offers a total prize of CHF 100,000, which will be equally divided among the winners if there is more than one, with each recipient receiving an award medal and a certificate.

The 2026 Tu Youyou Award is open for nominations until 31 October 2026. We encourage all eligible candidates to participate in this prestigious recognition, as this award not only honors individual achievement but also encourages further scientific exchange, exploration and discovery in critical areas of medicine.

If you are interested in participating, please visit the Tu Youyou Award website for more information on the nomination requirements.

23 April 2026
Proteomes | Interview with One of the Authors—Dr. Shantanu Gupta


Name: Dr. Shantanu Gupta
Affiliation: Bioinformatics Multidisciplinary Environment (BioME) – Digital Metropole Institute (IMD), Federal University of Rio Grande do Norte (UFRN), Natal, RN, Brazil

“DNA Damage-Induced Ferroptosis: A Boolean Model Regulating p53 and Non-Coding RNAs in Drug Resistance”
by Shantanu Gupta, Daner A. Silveira, José Carlos M. Mombach and Ronaldo F. Hashimoto
Proteomes 2025, 13(1), 6; https://doi.org/10.3390/proteomes13010006
Available online: https://www.mdpi.com/2227-7382/13/1/6

We recently had the opportunity to interview Dr. Shantanu Gupta, one of the authors of a recent paper published in Proteomes (ISSN: 2227-7382). He generously shared his perspective on his research, the challenges he’s encountered, and his personal journey in the field. The following is a brief interview with Dr. Gupta:

1. Could you tell us a little bit about yourself and your paper?
My research journey is centered at the intersection of bioinformatics, systems biology, and the role of non-coding RNAs in cancer, with a focus on decoding how cells make life-or-death decisions. I began developing the computational framework for this paper during my time at the University of São Paulo, and I’m now expanding this research line as a Visiting Associate Professor at the Bioinformatics Multidisciplinary Environment (BioME)-IMD at the Federal University of Rio Grande do Norte (UFRN).
My perspective is continually sharpened by my active role as a peer reviewer for over 150 international journals, which provides a broad, real-time view of the field. This was crucial for our paper, where we addressed a central challenge in cancer treatment: why do some tumors become resistant to therapy?
We developed a Boolean network model that reveals how the p53 protein and key non-coding RNAs interact as a coordinated system. Rather than working in isolation, these molecules form a decision-making network that determines whether a cell will undergo ferroptosis—a potent form of cell death—or survive and contribute to drug resistance.
What makes our approach unique is its systems-level logic. The model explains how cancer cells bypass death mechanisms, suggesting new strategies to overcome treatment resistance. This work was a collaborative effort with my colleagues Daner A. Silveira, José Carlos M. Mombach, and Ronaldo F. Hashimoto, whose expertise was invaluable. We were fortunate to have support from FAPESP and CNPq, without which this research would not have been possible.

2. What do you think made the academic community respond to your work so positively?
I believe that several factors contributed to the positive response. First, we addressed a genuine clinical problem—therapy resistance—that virtually every cancer researcher encounters. Second, by connecting established pathways like p53 with emerging fields like ferroptosis, we provided a bridge between different scientific communities.
The timing was also right. There's growing recognition that we need systems-level approaches to understand complex diseases like cancer. Our Boolean model offered an accessible yet powerful way to visualize these complex interactions. Perhaps most importantly, we didn’t just present data but offered a conceptual framework and testable hypotheses, encouraging collaboration across disciplines and inspiring new lines of investigation.

3. What do you think is the biggest challenge currently and the future directions in your area of research?
The biggest challenge remains cancer heterogeneity—each tumor, and even different regions of the same tumor, behaves uniquely. Capturing this complexity in models is extremely difficult.
Looking forward, I see the future in multi-scale, personalized systems modeling—integrating multi-omics data, signaling dynamics, and patient-derived information to
build digital representations of tumors. At BioME–IMD, UFRN, we are actively working toward this vision, developing computational frameworks that adapt as tumors evolve.
Such models could one day serve as predictive tools for precision oncology, helping clinicians simulate therapeutic responses before actual treatment. This integrative approach, combining systems biology with patient-centered data, is key to transforming computational discoveries into clinical impact.

4. What advice would you give to young scholars seeking to get into academia or publish their work?
I’d emphasize three principles that have guided my career.
First, cultivate intellectual fearlessness—don’t hesitate to work at the interface of disciplines. My own background in physics has deeply influenced how I think about biological systems. Physics teaches us to search for underlying principles and patterns, and that mindset is incredibly powerful when applied to the complexity of life sciences. Some of the most transformative discoveries happen when physics, biology, computation, and medicine converge.
Second, embrace the iterative nature of science. Each paper adds a piece to a larger puzzle. Your first work doesn’t need to answer everything—it just needs to ask the right, meaningful questions that move the field forward.
Third, engage deeply with the scientific community. This goes beyond just publishing. For me, this has meant taking on roles as an editorial board member for several journals. This experience isn't just about a title; it's a front-row seat to the publishing process, teaching you what makes a paper compelling, robust, and impactful—lessons you can directly apply to your own work. Collaboration and mentorship are the lifeblood of research. Be open, generous, and persistent—the rest will follow.

5. What is your impression of the publishing experience with the Proteomes journal?
My publishing experience with Proteomes was exceptionally positive. The peer review process was rigorous yet deeply constructive—the reviewers posed challenging questions that significantly improved the manuscript’s clarity and depth.
What stood out most was the journal’s commitment to intellectual quality over speed or profit. The editorial team fostered a genuine scientific dialog rather than a transactional process, and our revision rounds felt collaborative and purposeful.
I also appreciate the journal’s author-centered initiatives, like this interview series, which allow researchers to share the story behind their science and connect with a broader audience. It reflects a true dedication to advancing thoughtful, high-impact research within the scientific community.

6. How do you manage your time between research and daily life? Do you have any tips to share?
For me, effective time management is about balancing focused work with meaningful personal time. I dedicate mornings to deep research and writing, when concentration is highest. Afternoons are usually reserved for meetings, collaboration, mentoring, and my scholarly service work including peer review and editorial board responsibilities. Evenings often include teaching undergraduate and postgraduate students. Engaging with students and colleagues keeps me energized and frequently inspires new research ideas.
Equally important is making time for family. Sharing moments with them helps me recharge and maintain perspective, which is essential for sustaining creativity and productivity. Living in Natal, with its beautiful green-blue ocean and serene surroundings, makes it easier to enjoy these moments fully.
Ultimately, sustaining a research career is about rhythm—knowing when to dive deeply into the lab, classroom, or meetings, and when to pause to share time with family and reflect. Much like the rhythm of the ocean here in Natal, balance between intensity and stillness sustains both creativity and well-being, allowing science to remain not just a pursuit, but a passion.

16 April 2026
MDPI’s Newly Launched Journals in the First Quarter of 2026


Our portfolio of journals available for publishing up-to-date research in immediate open access format has been further expanded. In the first quarter of 2026, nine new journals released their inaugural issues and three transferred journals released their first issue as part of MDPI, covering the subjects of clinical medicine, chemistry, computer science & mathematics, engineering, environment & ecology, and social sciences & psychology.

We extend our gratitude to the Editors-in-Chief, Associate Editors, and Editorial Board Members who will shape the future course of these brand-new journals. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.

Please feel free to browse and discover more about the new journals below.

New Journals

Founding Editor(s)-in-Chief

Journal Topics (Selected)

Prof. Dr. Matt Oehlschlaeger,
Rensselaer Polytechnic Institute, USA
Editorial | view inaugural issue

AI-based chemical data analysis, prediction, and discovery; AI-enabled chemical reaction prediction, synthesis planning, and retrosynthesis; AI in bioorganic chemistry and chemical biology; digital twins and simulation of chemical processes; AI-powered chemical education and pedagogy |
view journal scope | submit an article

Prof. Dr. Guang Jia,
Peking University, China
Editorial | view inaugural issue

occupational hazards and exposure science; occupational health effects and susceptibility; occupational risk assessment and management; occupational health intervention, promotion, and policy |
view journal scope | submit an article

Prof. Dr. Alessandro Miani,
Italian Society of Environmental Medicine (SIMA), Italy
University of Milan, Italy
Prof. Dr. Jing Shang,
Peking University, China
Editorial | view inaugural issue

environmental exposures and health; the built environment and public health; One Health approach; environmental justice and health equity; environmental policies and interventions |
view journal scope | submit an article

Prof. Dr. Miriam H. A. Bopp,
Marburg University, Germany
Center for Mind, Brain and Behavior (CMBB), Germany
Prof. Dr. Christopher Nimsky,
Marburg University, Germany
Center for Mind, Brain and Behavior (CMBB), Germany
Editorial | view inaugural issue

neuroimaging technology and tool; multimodal neuroimaging integration and analysis;
dynamic modeling of brain networks; neuroimaging big data and cloud computing; translational and preclinical neuroimaging |
view journal scope | submit an article

Prof. Dr. Raul A. Urrutia,
Medical College of Wisconsin, Milwaukee, USA
Editorial | view inaugural issue

personalized translational and clinical oncology research that contribute to a deeper understanding of cancer diagnoses, prognoses, prevention, and treatment specifically for individual patients |
view journal scope | submit an article

Prof. Dr. Pierre Boulanger,
University of Alberta, Canada
Editorial | view inaugural issue

AI in disease detection, diagnosis, prediction, and treatment; medical informatics; AI in genomics and precision medicine; AI in drug discovery and development;
AI in healthcare; intelligent devices and instruments |
view journal scope | submit an article

Prof. Dr. Zhaokui Wang,
Tsinghua University, China
Editorial | view inaugural issue

astrodynamics; spacecraft technology; satellite technology; space transportation; space vehicle design, propulsion, and avionics; space energy, power and propulsion |
view journal scope | submit an article

Prof. Dr. Richard J Hauer,
University of Wisconsin–Stevens Point, USA
Editorial | view inaugural issue

park design, planning, and evaluation; park and art; park, industrialization, urbanization, and civilization; park and education; park and smart society; park role in SDGs;

park services for humans |
view journal scope | submit an article

Prof. Dr. Stacey L. Connaughton,
Purdue University, USA
Editorial | view inaugural issue

conflict resolution; peacebuilding; peacemaking; mediation, reconciliation, and transitional justice; sustaining peace |
view journal scope | submit an article

Transferred Journals

Editor(s)-in-Chief

Journal Topics (Selected)

Prof. Dr. Gianluigi Vendemiale,
University of Foggia, Italy
Editorial | view first issue

physiology and pathology of aging; biogerontology; epidemiology; clinical geriatrics; pharmacology; geriatric nursing |
view journal scope | submit an article

Prof. Dr. Michele Maffia,
University of Salento, Italy
Prof. Dr. Prisco Piscitelli,
Italian Society of Environmental Medicine, Italy
Editorial | view first issue

cellular and developmental biology; physiology, pathophysiology and endocrinology; diagnostic tools, therapies and public health |
view journal scope | submit an article

Dr. Warren S. Joseph,
American Podiatric Medical Association, USA
Editorial | view first issue

foot and ankle medicine; podiatric medicine |
view journal scope | submit an article

We would like to thank everyone who has supported the development of open access publishing. If you would like to create a new journal, you are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com).

7 April 2026
Proteomes | Interview with Dr. Scott Bringans on Blood-Based Diagnostics for Esophageal Cancer


Name:
Dr. Scott Bringans
Affiliation: Proteomics International, Broadway, P.O. Box 3008, Perth 6009, WA, Australia

“A Clinical Validation of a Diagnostic Test for Esophageal Adenocarcinoma Based on a Novel Serum Glycoprotein Biomarker Panel: PromarkerEso”
by Jordana Sheahan, Iris Wang, Peter Galettis, David I. Watson, Virendra Joshi, Michelle M. Hill, Richard Lipscombe, Kirsten Peters and Scott Bringans
Proteomes 2025, 13(2), 23; https://doi.org/10.3390/proteomes13020023
Available online: https://www.mdpi.com/2227-7382/13/2/23

In this interview, Dr. Scott Bringans shares insights into the research, its reception, and the broader impact of proteomics in clinical diagnostics. The following is a brief interview with Dr. Bringans:

1. Could you please tell us a little about yourself and your recent paper?
I am the Head of Research at Proteomics International in Perth, Australia, where I’ve been working for about 20 years. My background is in proteomics and protein chemistry, with a particular focus on using mass spectrometry as a tool to understand proteins.
Our paper presented the development of PromarkerEso, a novel blood-based diagnostic test for esophageal adenocarcinoma. This cancer type has very poor five-year survival rates—around 20%—and incidence has increased by 600% in Western countries since the 1970s.
Currently, diagnosis relies on invasive endoscopy and biopsy, which is costly and not suitable for large-scale screening. We developed PromarkerEso as something a bit more accessible, a blood test that measures a unique signature of glycoprotein biomarkers using mass spectrometry. Combined with clinical factors, the test provides a risk score to identify those likely to have, or not have, the disease.

2. What do you think led to the strong positive response from the academic community?
The positive reception came from both the clinical urgency and the technical innovation. Esophageal cancer is difficult to detect early, and existing diagnostic tools are invasive. Our blood-based test offers a non-invasive, accessible alternative.
On the technical side, our approach used lectin-based pull-down combined with targeted mass spectrometry, allowing us to detect specific glycoproteoforms that are often overlooked but can be incredibly informative in cancer biology.
Equally important was the rigor of our validation. We tested across three independent cohorts and achieved consistent results, with area under the curve (AUC) values between 0.82 and 0.98. This demonstrated that the test was not just a research outcome, but a clinically relevant application.

3. What are the main challenges and future directions in this area of research?
The biggest challenge is clinical translation. Moving from a strong research result to a diagnostic test used in routine clinical care involves navigating regulatory pathways, reimbursement policies, and integration into existing clinical workflows. It also requires building trust with clinicians who will ultimately use the test.
Long-term studies are needed to show that PromarkerEso can detect cancer early enough to make a difference in patient outcomes. And for aggressive conditions like esophageal cancer, early detection matters a lot. Proteomics can reveal subtle protein shifts before symptoms appear, allowing intervention while treatment is still effective. It’s a clear example of screening that actually changes treatment, rather than just providing information.
Our vision is to transition this into a high-throughput diagnostic offering which we are currently doing with potentially these types of tests becoming available as a point-of-care platform, making early detection more accessible worldwide, including in resource-limited settings.

4. What advice would you give to young scholars entering academia or beginning to publish their work?
Be passionate about what you are doing and clear about what you are trying to achieve. Research should not be for the sake of research alone—always consider what problem you are solving and what impact your work could have.
At Proteomics International, even our earliest projects are designed with an eye on clinical relevance. Setting long-term goals helps guide your work and provides motivation. Publishing should come as a natural result of doing good science with a clear purpose.

5. How was your publishing experience with Proteomes?
The process was smooth and efficient. We received fast feedback, both in terms of scientific review and the technical support needed to prepare the manuscript. The review process was rigorous yet timely, and the platform was easy to use. Compared to many journals, this was a particularly positive experience.

6. Finally, how do you balance research with daily life?
Work–life balance is important. At Proteomics International, we work hard but also make time for rest and reflection. Often the best solutions to complex problems come when you step away and allow your mind to work in the background.

For me, maintaining perspective, seeking input from others, and remembering why I am doing the work in the first place helps prevent burnout. When the goals are clear and the team is motivated—as with this project—it creates an exciting and enjoyable environment for scientific discovery.

We thank Dr. Bringans for taking the time and sharing his expertise. Wishing him all the best with his research and upcoming publications!

3 April 2026
Proteomes Outstanding Reviewer Award—Winner Announced


We are pleased to announce the winner of the Proteomes 2025 Outstanding Reviewer Award. The Editorial Board and editorial team of Proteomes (ISSN: 2227-7382) would also like to acknowledge the time and effort dedicated by reviewers in evaluating manuscripts submitted to this journal, which has maintained Proteomes’ reputation for high quality and quick turnaround.

Winner:

  • Dr. Alex Schmidt, University of Basel, Switzerland.

Prize:

  • CHF 500;
  • A certificate;
  • A voucher to waive the Article Processing Charges (APCs) for one submission to the journal (subject to peer review)—valid for one year.

Proteomes Editorial Office

2 April 2026
2026 Tu Youyou Award—Open for Nominations


We are delighted to announce that nominations are now open for the 2026 Tu Youyou Award. Named after Nobel Laureate Tu Youyou, whose discovery of artemisinin has saved millions of lives, this award recognizes researchers whose work advances the fields of natural products chemistry and medicinal chemistry, while also contributing to human health.

Prize

– CHF 100,000;
– A medal;
– A certificate.

The monetary prize will be shared equally should there be multiple recipients.

Who May Be Nominated?

– Scientists with outstanding achievements and contributions in the fields of natural products chemistry and medicinal chemistry.

Nominees must be individuals; team or group nominations are not permitted. Nominations are valid only for the current award cycle.

Who May Submit a Nomination?

– The director of the nominee’s host research institution or recognized scientists within the field.

Self-nominations will not be considered.

Nomination Materials

– A biographical sketch;
– A detailed description of the nominee’s contributions;
– 5–10 representative academic publications;
– A list of academic honors, awards, and funded projects;
– A nomination letter signed by two nominators.

How to Submit?

Submit nominations online via the following link: https://tuyouyouprize.org/nomination

Important Dates

– Nomination Deadline: 31 October 2026
– Winner Announcement: March 2027

For further information, please visit the Tu Youyou Award website (https://tuyouyouprize.org/). For any inquiries, please contact the Tu Youyou Award Team at tuyouyouaward@mdpi.com.

31 March 2026
MDPI INSIGHTS: The CEO’s Letter #33 - 2025 Annual Report, Preprints.org, IWD, Recapping Viruses 2026 & Romania Salon

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Scaling Open Access with Integrity: MDPI Annual Report 2025

I am pleased to share the release of MDPI’s 2025 Annual Report, reflecting our continued progress as one of the world’s leading open access publishers. The report highlights not only our growth, but also the continued evolution of our publishing model and our commitment to quality, transparency, and collaboration.

You can explore the full report here: https://mdpi-res.com/data/mdpi_annual_report_2025_0401.pdf?1775045421

Or visit the interactive page: https://www.mdpi.com/annual-report-2025/

A Year of Growth and Responsibility

2025 was a year of significant growth for MDPI. We received over 669,000 manuscript submissions, the highest in our history, while maintaining a rejection rate above 60%, reinforcing our commitment to both scale and quality.

We published 261,576 peer-reviewed open access articles across a portfolio of 500 journals, supported by a global community of more than 68,000 Editorial Board Members and 209,000 reviewers.

Scaling with Integrity

Growth alone is not the objective; how we grow matters.

Our 2025 Annual Report, Scaling Open Access with Integrity, reflects our continued focus on building the systems and processes that support reliable and trustworthy publishing. As submission volumes increase globally, so too does the importance of robust editorial workflows, research integrity frameworks, and the infrastructure required to support them.

In 2025, we continued to invest in:

  • Research integrity and quality assurance processes
  • Editorial support and reviewer engagement
  • Transparency across the publishing workflow

These efforts ensure that scale does not come at the expense of rigor, but rather reinforces it.

Validation Through Indexing and Visibility

As MDPI continues to grow, validation of quality remains essential.

In 2025, the number of MDPI journals indexed in the Web of Science Core Collection increased from 298 to 329, while Scopus coverage reached 355 journals, including 45 new acceptances. Coverage in major biomedical databases (PMC/Medline/PubMed) expanded to 95 journals, and indexing in Ei Compendex increased significantly.

These milestones reflect the strength of our editorial processes and the trust placed in our journals by independent indexing bodies.

Importantly:

  • 96% of all MDPI articles are indexed in Web of Science databases
  • More than 1.75 million articles are indexed, with an average of 13 citations per article

Recognition through Journal Citation Reports also continues to grow:

  • 298 journals received Impact Factors
  • 65% ranked in the top half of their categories
  • 61 journals achieved top-quartile positions

These developments demonstrate that growth and quality are advancing together, supported by strong editorial oversight and consistent performance across our journal portfolio.

Strengthening Partnerships and Community

Open access is a collaborative endeavor.

In 2025, we expanded our institutional partnerships to more than 1,000 IOAP agreements, helping simplify publishing for researchers and institutions worldwide.

We also hosted 60 in-person conferences and virtual events, bringing together more than 28,000 participants to exchange ideas, share research, and strengthen connections across the global scientific community.

At the heart of everything we do is this community of authors, editors, reviewers, and partners who make open science possible.

Looking Ahead

Open access continues to move toward becoming the standard model for sharing research globally. With that growth comes increased responsibility.

Our focus moving forward is to continue building a publishing ecosystem that is:

  • Collaborative, to serve the research community
  • Rigorous, to ensure quality
  • Transparent, to support trust
  • Scalable, to meet global demand

We believe that open access, when combined with strong editorial standards and integrity, is the most effective way to accelerate scientific progress.

Thank you to all the scholarly community who collaborated with us and our MDPI staff for your continued dedication and contributions in making 2025 a successful year.

Impactful Research

Celebrating Ten Years of Preprints.org: Accelerating Open Research

In 2026, MDPI’s preprints server Preprints.org marked its 10th anniversary as a platform dedicated to accelerating the dissemination of research. Since its launch, Preprints.org has grown into a global platform that hosts more than 120,000 preprints contributed by hundreds of thousands of researchers worldwide, generating tens of millions of views and downloads and demonstrating the value of sharing research openly and rapidly.

At MDPI, we are proud to celebrate ten years of Preprints.org supporting the mission of open science. Over the past decade, we have seen how early sharing of research can accelerate collaboration and help ideas move more quickly from discovery to impact.

The Evolution of Preprints

While Preprints.org launched in 2016, the idea behind it has deeper roots. The concept of rapid research dissemination has existed for decades, with early preprint servers showing how open sharing can accelerate scientific progress.

Over the past decade, preprints have become an increasingly important part of scholarly communication. Researchers across disciplines are looking at faster ways to share their discoveries, exchange ideas, and receive feedback from the global scientific community.

Preprints in a Growing Research Ecosystem

The global preprint landscape has expanded significantly over the past decade, with multiple platforms serving different research communities. The figure below (sourced from James Butcher newsletter), based on data from Dimensions (Digital Science), shows the growth of preprint outputs across several major platforms over time.

Among these platforms, arXiv (the pioneering preprint server) has experienced great growth in recent years. At the same time, other platforms have continued to expand their reach across disciplines, capturing increasing global interest in early research sharing.

Preprints.org contributes to this evolving ecosystem by providing a multidisciplinary platform that works in synergy with academic journals, helping researchers bridge the gap between rapid dissemination and the formal publication process.

Celebrating the First Decade

To commemorate this milestone, Preprints.org launched a 10th Anniversary celebration hub highlighting the impact of preprints and the researchers who contribute to them.

One of the central initiatives is the Popular Preprints of the Decade Award, recognizing influential preprints published between 2016 and 2026 across multiple research fields. Through community voting, the award will recognize research that has generated high engagement and visibility within the global research community.

Looking Ahead: The Next Decade of Preprints

As research communication continues to evolve, preprints will continue to play an important role in enabling faster collaboration, improving transparency, and expanding access to knowledge. The next decade may bring further integration between preprint platforms and journals, new tools for discovery and evaluation, and greater global participation in open science.

At MDPI, we remain committed to supporting researchers through platforms that encourage the open exchange of ideas. The success of Preprints.org over the past ten years reflects the engagement and trust of the global research community – authors, readers, reviewers, and collaborators who believe in the value of sharing knowledge openly.

Congratulations to everyone involved in the development and growth of Preprints.org over the past decade!

Inside MDPI

Beyond International Women’s Day: Supporting Women in Research

International Women’s Day (IWD) offers an opportunity to recognize the achievements of women around the world and reflect on how we can continue building a more inclusive future. In research and academia, this conversation carries particular importance, as scientific progress depends on diverse perspectives, and supporting women in science is essential to strengthening the global research ecosystem.

For MDPI, IWD is an opportunity to celebrate the achievements of women in research and highlight the initiatives, conversations, and collaborations that help support researchers across disciplines and career stages.

Highlighting Women in Science Across MDPI

This year, MDPI marked International Women’s Day with a global campaign highlighting research, awards, and perspectives that support women in science. Throughout the week, our teams shared content across MDPI’s social media channels sharing the work of women researchers and encouraging engagement across the academic community.

As part of this initiative, MDPI published several blog articles exploring important themes related to gender equity in research. One article, Give Support, Gain Progress: Retaining Women in Science, discusses the importance of mentorship, institutional support, and inclusive research environments in helping women build sustainable scientific careers.

Another featured article, Bridging the Gap in Women’s Health Research, highlights the ongoing need to address disparities in health research and ensure that women’s health receives the scientific attention and investment it deserves.

These topics capture the notion that supporting women in science benefits not only individual researchers but the entire scientific community. When researchers from diverse backgrounds can contribute their perspectives and ideas, the scope and impact of scientific discovery expand.

Creating Spaces for Dialogue

Beyond online content, MDPI is also supporting conversations about women in research through community engagement.

On 10 March, MDPI UK hosted the “Women in Research” event, bringing together researchers and professionals to share experiences and discuss the opportunities and challenges women face throughout their scientific careers. Events like these are an opportunity for open dialogue, mentorship, and networking to create more inclusive research communities.

Looking Beyond a Single Day

While IWD is an important moment of recognition, progress requires ongoing effort.

Supporting women in research involves many forms of engagement: from mentorship and collaboration to creating inclusive environments in which diverse voices are heard and valued. Publishers, institutions, and researchers all play a role in building this ecosystem.

At MDPI, we remain committed to supporting the global research community and to promoting open access publishing as a foundation for accessible and inclusive knowledge-sharing.

As we reflect on IWD this year, we recognize the many women who contribute to research as authors, reviewers, editors, mentors, and educators; we also recognize the impact they continue to have on the advancement of science. The influence of women in research extends far beyond a single day of recognition, reminding us that supporting them is a commitment that continues throughout the year.

Coming Together for Science

Highlights from Viruses 2026 – New Horizons in Virology (11–13 March)

Through 11–13 March, we successfully delivered the Viruses 2026 – New Horizons in Virology MDPI conference in Barcelona, bringing together an international community of researchers, editors, and partners dedicated to advancing the field of virology.

Conference Highlights

Viruses 2026 in numbers:

  • 198 total registrations, with 171 attendees on site
  • 233 submissions, with 122 accepted
  • 42 short talks, 9 flash talks, and 80 posters
  • 13 invited speakers and 1 keynote speaker

The strong level of participation and quality of submissions once again demonstrate the relevance of the Viruses community.

A standout moment was the keynote lecture by Dr. Ho, which also attracted an NBC documentary film crew, highlighting the broader impact of the research being presented.

Scientific Programme

The conference programme covered areas across modern virology, including viral replication, pathogenesis, immunology, and public health. Sessions explored topics on antiviral therapeutics and vaccines, innate immunity, virus–host interactions, and the structure and mechanisms of virus replication.

Together, these discussions highlighted both the fundamental biology of viruses and the translational challenges of addressing emerging infectious diseases, reflecting the breadth and continued importance of virology research in a global context. The programme also included a sponsored workshop on research data management in virology, further emphasizing the importance of data practices in advancing the field.

Thank You

Feedback from participants has been very positive, and I would like to thank the Conference team for the organization and delivery of this year’s event.

Thank you to our Viruses journal team and all colleagues involved behind the scenes in supporting the delivery of the event. As noted by Dr. Eric Freed (EiC of Viruses), the success of this edition gives us strong momentum as we look ahead to the next conference in 2028, with opportunities to further expand participation and engagement.

Closing Thoughts

Recap from MDPI Romania Salon in Cluj-Napoca (24 March)

On 24 March, we had the opportunity to meet with members of the Romanian research community in Cluj-Napoca at our MDPI Romania Salon. The event was a space for presentations, open discussion, and the exchange of perspectives on publishing and the research landscape in Romania.

We welcomed 39 participants, including 27 researchers from institutions across Romania, representing cities such as Cluj-Napoca, Timișoara, and Reșița. Among them were Editorial Board Members, Associate Editors, and Guest Editors, all of whom play an important role in collaborating with MDPI and shaping the quality and direction of academic publishing.

A Shared Commitment to Research Excellence

These events reflect MDPI’s commitment to connecting with and supporting researchers by means of transparency, dialogue, and collaboration. During the day, MDPI colleagues shared a series of presentations covering different parts of our publishing ecosystem:

  • MDPI’s presence in Romania – Anamaria Vartolomei (Journal Relationship Specialist (JRS), Section Managing Editor (ME))
  • MDPI’s performance, growth, and impact in Romania – Stefan Tochev (CEO)
  • Academic services, initiatives, and projects supporting researchers – Ioana Preda (JRS, Section ME)
  • Best practices and standards in publication ethics – Lavinia Rogojina (Research Integrity Manager)
  • Panel session on ethics, AI, and peer review – Lavinia Rogojina, Ioana Preda, Doris Larisa Albu (JRS, Section ME), Cristina Georgiana Spelmezan (JRS, Section ME)
  • Closing remarks – Lavinia Dumitrela Cozma (Operations Manager, Section ME)

Feedback from participants was very positive, particularly regarding the quality of discussions, the relevance of the topics, and the opportunity to engage directly with MDPI colleagues. What stood out most was the openness of the discussion. These events are important not only for the purposes of presenting what we do, but also as an opportunity to listen, understand concerns, and continue to build alignment with the research community.

Romania and the Growth of Open Access Publishing

The Romanian research landscape continues to show growth in open access (OA) publishing.

In 2025:

  • 72% of all publications in Romania were published as OA
  • Of these, 74% were Gold Open Access

Over the past five years, Romania has produced more than 109,000 publications, with approximately 71% available openly, highlighting a sustained shift toward accessibility and knowledge-sharing.

Within this landscape, MDPI continues to play a significant role:

  • MDPI is the leading OA publisher in Romania, contributing 42% of all OA publications in 2025
  • More than 37,000 articles have been published with MDPI by Romanian institutions since 1996
  • This figure includes over 7,500 publications in 2025 alone
  • More than 400 Editorial Board Members from Romania collaborate with MDPI across disciplines

These trends show the growth of OA and the strength of collaboration between MDPI and the Romanian research community.

Looking Ahead

As academic publishing continues to evolve, maintaining open and transparent communication with researchers is essential. Events such as our Salons and Summits provide great opportunities to exchange perspectives and to build trust and collaboration.

Thank you to all participants who joined us in Cluj, and to our teams in Romania for delivering a successful event. A special thank-you to Alina-Florina Agafitei (Marketing Specialist) for her care and attention to detail in delivering the Salon.

Stefan Tochev
Chief Executive Officer
MDPI AG

Back to TopTop